查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1912776

醫用血栓彈力圖設備市場（按產品類型、技術、應用和最終用戶分類）—2026-2032年全球預測

Medical Thromboelastography Machine Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，醫用血栓彈力圖設備市場價值為6.6527億美元，預計2026年將成長至7.2011億美元，年複合成長率為8.53%，到2032年將達到11.8027億美元。

關鍵市場統計數據
基準年 2025 6.6527億美元
預計年份：2026年 7.2011億美元
預測年份 2032 11.8027億美元
複合年成長率 (%) 8.53%

不斷發展的臨床、技術和營運環境正在影響血栓彈力圖在醫療機構和外科專科中的應用方式。

血栓彈力圖的臨床和商業性應用已發展成為一個複雜的生態系統，該技術與患者預後和治療路徑直接相關。醫院和專科外科團隊越來越依賴即時凝血功能分析來指南輸血決策並減少手術全期併發症。同時，攜帶式設備和新型分析方法的進步正在拓展黏彈性檢測的應用範圍，從手術室、創傷室到門診，均可應用。

探索推動黏彈性血液凝固檢驗技術加速應用並重新定義其價值主張的技術、臨床和商業性轉折點

多項變革正在發生，重新定義血栓彈力圖系統的效用和市場趨勢。首先，照護現場技術的成熟降低了床邊檢測的門檻，從而能夠更快地獲得結果並即時治療性介入。這正在改變診療路徑，尤其是在重症患者中，幾分鐘的時間可能對血液製品的使用和患者預後產生重大影響。因此，臨床通訊協定和醫院工作流程正在重新設計，將黏彈性資料納入圍手術全期和創傷管理的標準流程中。

評估不斷變化的關稅和貿易趨勢如何重塑血栓彈力圖解決方案供應鏈的韌性、採購行為和成本結構。

關稅環境會影響醫療設備（包括血栓彈力圖系統及其相關耗材）的成本結構和分銷動態。進口關稅和貿易措施的變化會導致依賴跨境製造和零件採購的供應商的到岸成本波動，進而影響其定價策略和利潤率。為此，許多製造商正在重新審視其供應鏈結構，尋求零件多元化和區域組裝，以降低關稅波動帶來的風險，同時保持對醫院和檢查室的競爭力價格。

挖掘不同終端使用者環境、產品形式、臨床應用和技術模式下的細微需求促進因素，並確定策略重點。

基於細分市場的洞察揭示了臨床需求與營運能力相契合的領域，以及商業性機會最為顯著的領域。依照最終使用者分析發現，門診手術中心、診斷檢查室、醫院和研究機構的需求模式有顯著差異，而醫院內部的複雜性又因二級醫院和三級醫院的區分而進一步增加。二級醫療機構傾向於優先考慮兼具成本效益和可靠圍手術全期指導的系統，而三級醫療機構則更重視先進的分析能力和整合性，以支持複雜的手術以及專業的移植和心臟項目。門診手術中心優先考慮吞吐量和緊湊的面積，而診斷檢查室重視分析的可重複性和對認證標準的符合性。研究實驗室則重視柔軟性的配置以滿足研究通訊協定的需求。

分析區域醫療保健結構、監管差異和採購規範如何影響美洲、歐洲、中東和非洲以及亞太地區的醫療衛生保健模式的採用。

區域趨勢正以不同的方式影響全球市場的籌資策略、監管預期和臨床應用模式。在美洲，整合式醫療模式、不斷演變的報銷機制以及三級醫療機構的集中發展推動了臨床指南的採納，這些因素都在影響著醫療保健系統。在這種環境下，能夠透過同儕審查的證據證明其臨床效用，並透過完善的售後培訓和分析服務來支持複雜的採購流程的供應商更具優勢。

識別決定黏彈性測試市場領導地位並影響採購決策的競爭策略和能力差異化因素

血栓彈力圖領域的競爭由技術差異化、臨床證據產生以及提供能夠減少組織摩擦的端到端解決方案的能力共同驅動。市場領導通常將可靠的硬體平台與先進的軟體分析、耗材供應鏈和強大的臨床支援服務相結合。新參與企業則傾向於透過強調便攜性、直覺的使用者介面和更低的整體擁有成本來挑戰現有企業，以吸引門診和基層醫療機構。

為製造商和醫療保健領導者提供以行動為導向的策略指南，以加速臨床應用、減少障礙並提升長期價值創造。

產業領導者應採取多維度策略，整合臨床證據、產品設計和商業性執行，以加速產品普及並維持成長。首先，應優先投資於以臨床為導向的研究和真實世界證據項目，以證明設備表現與輸血決策、併發症率和手術全期效率的顯著改善有關。可證實的臨床影響有助於降低支付方的阻力，並加強與醫院採購委員會的對話。

我們採用透明的多方法研究方法，將主要臨床發現與嚴格的二次分析相結合，以確保可靠的策略指導和可追溯性。

支持這些發現的研究採用了一種多方法途徑，整合了定性和定量資料來源，以確保全面涵蓋臨床、監管和商業性方面。關鍵投入包括對臨床醫生、檢查室主任和採購專業人員進行結構化訪談，以深入了解工作流程的限制、決策標準和感知價值促進因素。二次研究涉及對同行評審的臨床文獻、監管文件和上市公司資訊披露的綜合分析，以梳理技術差異化因素和證據成熟度。

整合了臨床檢驗、整合和營運準備如何定義黏彈性血液凝固檢驗未來角色的策略意義

血栓彈力圖技術在臨床需求與技術創新之間佔據著策略性地位，為改善各種醫療環境中的凝血管理提供了切實可行的方案。推動其普及應用的因素包括：對快速照護現場能力、高級分析功能以及臨床和經濟價值證據的日益成長的需求。然而，成功應用需要將設備功能與不同臨床環境下的操作實踐進行精心匹配，包括培訓、工作流程整合和資料互通性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的醫用血栓彈力圖設備市場

  • 桌上型系統
  • 可攜式系統
    • 電池供電系統
    • 市電連接系統

9. 按技術分類的醫用血栓彈力圖設備市場

  • 共振血栓彈力圖
  • 旋轉血栓彈力圖
  • 聲流變分析

第10章 依應用分類的醫用血栓彈力圖設備市場

  • 麻醉監測
  • 止血監測
  • 外科手術
    • 心臟手術
    • 肝臟移植
    • 整形外科手術
  • 創傷治療

第11章 以最終用戶分類的醫用血栓彈力圖設備市場

  • 門診手術中心
  • 診斷檢查室
  • 醫院
    • 二級護理醫院
    • 三級醫院
  • 研究所

第12章 區域性醫用血栓彈力圖設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫用血栓彈力圖設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國醫用血栓彈力圖設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫用血栓彈力圖設備市場

第16章：中國醫用血栓彈力圖設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Diagnostica Stago SAS
  • Guizhou Jinjiu Biotech
  • Haemonetics Corporation
  • HemoSonics LLC
  • Instrumentation Laboratory Company
  • Ortho Clinical Diagnostics LLC
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Sienco Inc.
  • Sysmex Corporation
Product Code: MRR-AE420CB13A8F

The Medical Thromboelastography Machine Market was valued at USD 665.27 million in 2025 and is projected to grow to USD 720.11 million in 2026, with a CAGR of 8.53%, reaching USD 1,180.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 665.27 million
Estimated Year [2026] USD 720.11 million
Forecast Year [2032] USD 1,180.27 million
CAGR (%) 8.53%

Contextualizing the evolving clinical, technological, and operational landscape shaping how thromboelastography is adopted across care settings and surgical specialties

The clinical and commercial environment for thromboelastography has evolved into a complex ecosystem where technology intersects directly with patient outcomes and care pathways. Hospitals and specialty surgical teams increasingly rely on real-time coagulation profiling to guide transfusion decisions and reduce perioperative complications. Concurrently, advances in portable instrumentation and novel analytic modalities have expanded the contexts in which viscoelastic testing can be deployed, ranging from operating rooms to trauma bays and ambulatory settings.

Against this backdrop, decision-makers face interlocking considerations: procurement and integration costs, staff training and competency, regulatory compliance, and the operational workflows required to translate raw device output into actionable clinical decisions. These dynamics have been further complicated by shifts in reimbursement practices and a growing emphasis on value-based care, which demand demonstrable improvements in clinical endpoints and cost-effectiveness. Translational research and user-driven innovation continue to push the field forward, creating both opportunities for differentiation and imperatives for rigorous clinical validation.

Exploring the pivotal technological, clinical, and commercial inflection points that are accelerating adoption and redefining value delivery in viscoelastic coagulation testing

Several transformative shifts are redefining both the utility and market trajectory of thromboelastography systems. First, the maturation of point-of-care capabilities has reduced barriers to bedside testing, enabling faster turnaround and more immediate therapeutic interventions. This has altered care pathways, particularly in high-acuity environments where minutes translate to meaningful changes in blood product utilization and patient outcomes. As a result, clinical protocols and hospital pathways are being redesigned to incorporate viscoelastic data as a standard component of perioperative and trauma management.

Second, advancements in analytic methods and sensor technologies-such as resonance-based analysis and improvements in signal processing-have increased the granularity and clinical interpretability of coagulation profiles. These technological refinements facilitate more nuanced differentiation between fibrinolytic and platelet-driven coagulopathies, thus informing targeted therapeutic strategies. Third, integration with hospital information systems and laboratory workflows is becoming a decisive factor: seamless interoperability reduces administrative friction and accelerates clinician uptake. Finally, commercial models are shifting from device-centric sales toward bundled solutions that include consumables, software analytics, and training, reflecting the need for comprehensive value propositions that align with institutional performance metrics.

Assessing how evolving tariff measures and trade dynamics are reshaping supply chain resilience, procurement behavior, and cost structures for thromboelastography solutions

The tariff environment can influence the cost structure and distribution dynamics for medical devices, including thromboelastography systems and associated consumables. Changes in import duties or trade measures may alter landed costs for suppliers that rely on cross-border manufacturing or component sourcing, thereby affecting pricing strategies and margins. In response, many manufacturers reassess supply chain architectures, seeking component diversification or regionalized assembly to mitigate exposure to tariff volatility while maintaining competitive pricing for hospitals and laboratories.

Beyond direct cost implications, tariffs can have downstream operational effects. Procurement cycles may lengthen as health systems re-evaluate vendor contracts and total cost of ownership, and some institutions may prioritize suppliers with localized manufacturing or established regional distribution networks to reduce exposure. Strategic responses by industry participants include renegotiation of supply agreements, hedging through multi-sourcing, and increased collaboration with local manufacturing partners. These adaptations are influencing product roadmaps and market entry strategies as firms balance resilience with the need to preserve accessible pricing for end users.

Uncovering nuanced demand drivers across end user environments, product formats, clinical applications, and technology modalities to pinpoint strategic priorities

Segmentation-based insights illuminate where clinical demand converges with operational capability and where commercial opportunities are most pronounced. When examined by end user, demand patterns differ meaningfully across Ambulatory Surgery Centers, Diagnostic Laboratories, Hospitals, and Research Institutes, with hospitals presenting layered complexity through distinctions between Secondary Care Hospitals and Tertiary Care Hospitals. Secondary care facilities often prioritize systems that balance cost-efficiency with reliable perioperative guidance, whereas tertiary centers emphasize advanced analytics and integration to support complex procedures and specialized transplant or cardiac programs. Ambulatory Surgery Centers prioritize throughput and compact footprint, diagnostic laboratories focus on analytical reproducibility and accreditation compliance, and research institutes value configurability for investigational protocols.

Product type segmentation similarly reveals divergent user priorities between Benchtop Systems and Portable Systems, the latter further differentiated into Battery Operated Systems and Mains Powered Systems. Benchtop platforms typically appeal to centralized laboratory environments where throughput and expanded testing menus matter most, while portable systems respond to bedside and intraoperative needs where rapid, point-of-care decision-making is paramount. Within portable offerings, battery operated configurations enable deployment in austere or mobile settings and during intra-hospital transport, whereas mains powered devices often provide extended run times and feature sets for continuous monitoring.

Application segmentation highlights the clinical workflows that drive value: Anesthesia Monitoring, Hemostasis Monitoring, Surgical Procedures, and Trauma Care are distinct use cases with unique performance and operational requirements. Surgical Procedures further segment into Cardiac Surgery, Liver Transplantation, and Orthopedic Surgery, each with specific hemostatic challenges and protocolized transfusion thresholds. Cardiac and transplant surgeries often demand high-resolution analytics to guide complex coagulation management, whereas orthopedic applications emphasize rapid exchange and streamlined perioperative algorithms to minimize blood loss and transfusion needs.

Finally, technology-based segmentation underscores choices among Resonance Thromboelastography, Rotational Thromboelastometry, and Sonorheometry Analysis. Each technology presents trade-offs in sensitivity, ease of interpretation, and integration pathways, and the selection often reflects a mix of clinical preference, existing laboratory infrastructure, and institutional priorities around training and quality assurance. Collectively, these segmentation lenses reveal where innovation will deliver the greatest clinical and commercial return and where adoption barriers will require targeted strategies to overcome.

Analyzing how regional healthcare structures, regulatory diversity, and procurement norms across the Americas, Europe Middle East & Africa, and Asia-Pacific influence adoption

Regional dynamics shape procurement strategies, regulatory expectations, and clinical adoption patterns in different ways across global markets. In the Americas, health systems are influenced by a mix of integrated care models, evolving reimbursement mechanisms, and concentrated centers of tertiary care that often drive clinical guideline uptake. This environment favors vendors that can demonstrate clinical utility through peer-reviewed evidence and that can support complex procurement processes with robust post-sale training and analytics services.

In Europe, Middle East & Africa, regulatory heterogeneity and diverse healthcare delivery infrastructures create differentiated pathways to market. Some countries prioritize centralized laboratory services and stringent compliance standards, while others emphasize decentralized care models where portable solutions gain traction. Strategic partnerships with regional distributors and clear alignment with local regulatory requirements are essential for sustained engagement. In the Asia-Pacific region, rapid hospital modernization and expanding surgical volumes are creating strong demand for technologies that can be scaled across heterogeneous facility types. Local manufacturing partnerships, culturally attuned training programs, and adaptable commercial models that address price sensitivity while preserving service quality are particularly important for successful market penetration in this region.

Across regions, interoperability, clinician education, and evidence of clinical impact remain universal enablers. Firms that tailor their offerings to regional procurement norms and which invest in localized support capabilities are better positioned to achieve clinical integration and long-term adoption.

Distilling competitive strategies and capability differentiators that determine leadership in viscoelastic testing markets and influence procurement decisions

Competitive dynamics in the thromboelastography field are shaped by a blend of technological differentiation, clinical evidence generation, and the ability to provide end-to-end solutions that reduce institutional friction. Market leaders typically combine reliable hardware platforms with sophisticated software analytics, consumable supply chains, and robust clinical support services. Newer entrants often seek to disrupt incumbent positions by focusing on portability, intuitive user interfaces, and lower total cost of ownership that appeal to ambulatory and peripheral care settings.

Partnerships and strategic alliances are common routes to scale, including collaborations with established laboratory systems, hospital groups, and academic centers to validate clinical utility and accelerate clinician adoption. Additionally, companies investing in longitudinal outcome studies and real-world evidence generation strengthen their value propositions for payers and procurement committees. Service excellence, including training programs, rapid technical support, and data integration capabilities, is increasingly a differentiator that influences long-term purchasing decisions. Finally, firms that can continuously iterate product features while maintaining regulatory compliance and supply chain resilience tend to sustain competitive advantage.

Action-oriented strategic directives for manufacturers and healthcare leaders to accelerate clinical adoption, reduce barriers, and enhance long-term value capture

Industry leaders should pursue a multi-dimensional strategy that integrates clinical evidence, product design, and commercial execution to accelerate adoption and sustain growth. First, prioritize investment in clinically oriented studies and real-world evidence programs that link device outputs to measurable improvements in transfusion decisions, complication rates, and perioperative throughput. Demonstrable clinical impact reduces payer friction and strengthens conversations with hospital procurement committees.

Second, focus on modular product architectures that allow institutions to scale from benchtop laboratory deployments to portable point-of-care units without necessitating wholesale replacement. This approach reduces procurement barriers and enables phased adoption tied to clinical workflow optimization. Third, develop comprehensive service and training bundles that address competency gaps and ensure consistent interpretation across multidisciplinary teams; clinician confidence in test interpretation is a decisive factor for routine use. Fourth, consider regional manufacturing or assembly partnerships to mitigate tariff exposure and shorten lead times, thereby improving price competitiveness and logistical resilience. Finally, pursue interoperable software solutions and API-enabled data exchange to integrate viscoelastic outputs into electronic health records and laboratory information systems, which enhances clinician utility and facilitates outcome tracking for quality initiatives.

Transparent, multi-method research approach combining primary clinical insights and rigorous secondary synthesis to ensure reliable strategic guidance and traceability

The research underpinning these insights was developed through a multi-method approach that integrated qualitative and quantitative data sources to ensure comprehensive coverage of clinical, regulatory, and commercial dimensions. Primary inputs included structured interviews with clinicians, laboratory directors, and procurement professionals, which provided contextual understanding of workflow constraints, decision criteria, and perceived value drivers. Secondary research involved synthesis of peer-reviewed clinical literature, regulatory documentation, and public company disclosures to map technology differentiators and evidence maturity.

Analytical steps included cross-validation of qualitative themes with observable indicators such as product launch timelines, regulatory approvals, and published clinical outcomes. Market narratives were stress-tested through scenario analysis to identify plausible responses to variables such as trade disruptions, reimbursement shifts, and rapid technology adoption. Throughout, rigorous attention was paid to source triangulation and bias mitigation to ensure that conclusions reflect a balanced assessment of opportunity and risk. The methodology emphasizes transparency in assumptions and provides traceability between primary insights and supporting evidence to enable informed decision-making.

Synthesizing strategic takeaways on how clinical validation, integration, and operational readiness will determine the future role of viscoelastic coagulation testing

Thromboelastography occupies a strategic position at the intersection of clinical need and technological innovation, offering tangible potential to improve coagulation management across a range of care settings. Adoption is being driven by the convergence of faster point-of-care capabilities, richer analytic modalities, and increasing demands for evidence of clinical and economic value. However, successful diffusion requires thoughtful alignment of device capabilities with the operational realities of diverse clinical environments, including training, workflow integration, and data interoperability.

Looking ahead, stakeholders who invest in high-quality clinical validation, deliver user-focused product experiences, and build resilient supply and service frameworks will be best positioned to translate technology potential into sustained clinical impact. Collaboration between manufacturers, clinical leaders, and institutional purchasers will be essential to align incentives and ensure that viscoelastic testing becomes an integrated component of modern perioperative and trauma care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Thromboelastography Machine Market, by Product Type

  • 8.1. Benchtop Systems
  • 8.2. Portable Systems
    • 8.2.1. Battery Operated Systems
    • 8.2.2. Mains Powered Systems

9. Medical Thromboelastography Machine Market, by Technology

  • 9.1. Resonance Thromboelastography
  • 9.2. Rotational Thromboelastometry
  • 9.3. Sonorheometry Analysis

10. Medical Thromboelastography Machine Market, by Application

  • 10.1. Anesthesia Monitoring
  • 10.2. Hemostasis Monitoring
  • 10.3. Surgical Procedures
    • 10.3.1. Cardiac Surgery
    • 10.3.2. Liver Transplantation
    • 10.3.3. Orthopedic Surgery
  • 10.4. Trauma Care

11. Medical Thromboelastography Machine Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals
    • 11.3.1. Secondary Care Hospitals
    • 11.3.2. Tertiary Care Hospitals
  • 11.4. Research Institutes

12. Medical Thromboelastography Machine Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Thromboelastography Machine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Thromboelastography Machine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Thromboelastography Machine Market

16. China Medical Thromboelastography Machine Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Diagnostica Stago S.A.S.
  • 17.7. Guizhou Jinjiu Biotech
  • 17.8. Haemonetics Corporation
  • 17.9. HemoSonics LLC
  • 17.10. Instrumentation Laboratory Company
  • 17.11. Ortho Clinical Diagnostics LLC
  • 17.12. Roche Diagnostics International AG
  • 17.13. Siemens Healthineers AG
  • 17.14. Sienco Inc.
  • 17.15. Sysmex Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BENCHTOP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BENCHTOP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BENCHTOP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BATTERY OPERATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BATTERY OPERATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY BATTERY OPERATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY MAINS POWERED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY MAINS POWERED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY MAINS POWERED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESONANCE THROMBOELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESONANCE THROMBOELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESONANCE THROMBOELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ROTATIONAL THROMBOELASTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SONORHEOMETRY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SONORHEOMETRY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SONORHEOMETRY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ANESTHESIA MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ANESTHESIA MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ANESTHESIA MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HEMOSTASIS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HEMOSTASIS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HEMOSTASIS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY LIVER TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY LIVER TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TRAUMA CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TRAUMA CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TRAUMA CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 170. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 173. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 181. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NATO MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY PORTABLE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA MEDICAL THROMBOELASTOGRAPHY MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)